Healthcare -
Biotechnology - NASDAQ - BM
$ 21.98
8.38 %
$ 1.6 B
Market Cap
-36.63
P/E
KNSA - CAPITAL EXPENDITURES
Capital Expenditures KNSA - Kiniksa Pharmaceuticals, Ltd.
-130 K
LAST VALUE
92.02%
2 YEAR CAGR
52.35%
5 YEAR CAGR
0.00%
10 YEAR CAGR